Primary study · included by 1 review

Characterizing and Targeting of BCL-2 Family Members in Nasopharyngeal Carcinoma.

Thai 2025 · Thai A A, Young R J, Bressel M, et al. · Head & neck · 2025

Included by

Prognostic Value of Bcl-xL in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Non-Cochrane · prognostic · 2026 · cited as Thai 2025 · Table 1; References; Table S1
Outcome this study informsPooled effectEvidenceCertainty
Overall survival
High tumoral Bcl-xL expression vs Low tumoral Bcl-xL expression
HR 1.12 [0.95, 1.32]3 studies · 236 participantsGRADE not reported

1 including review in total.